Multi-country Survey on Violence Against Women Among Medical Staff

February 11, 2025 updated by: Unnop Jaisamrarn, Chulalongkorn University

Multi-country Survey on Violence Against Women Among Medical Staff.

The goal of this observational study is to investigate the knowledge, attitude, and practice (KAP) towards violence against women (VAW) among medical staff in the Department of Obstetrics and Gynecology in Asia and Oceania countries

The main question it aims to answer is:

  • the KAP towards VAW among medical staff in the Department of Obstetrics and Gynecology in Asia and Oceania countries
  • the KAP towards support service of VAW among medical staff in the Department of Obstetrics and Gynecology in Asia and Oceania countries

Participants will be asked to complete the online self-administrated questionnaire.

Study Overview

Status

Not yet recruiting

Detailed Description

The medical staff in the Department of Obstetrics and Gynecology or Women Health Units are in an optimal position to address VAW.

This survey aimed to investigate 1) the KAP towards VAW among medical staff in the Department of Obstetrics and Gynecology in Asia and Oceania countries, and 2) KAP towards the support service of VAW among medical staff in the Department of Obstetrics and Gynecology in Asia and Oceania countries.

This multinational, cross-sectional study will be carried out using an online self-administrated questionnaire.

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Any medical staff in the Department of Obstetrics and Gynecology or Women Health Units, who are aged 18 and over, and agree to fill the questionnaire will be eligible to participate in this study. Medical staff are licensed healthcare providers (medical doctors, nursing staff, and others).

Description

Inclusion Criteria:

  • Any medical staff in Department of Obstetrics and Gynecology or Women Health Units, who are aged 18 and over and agree to fill out the questionnaire will be eligible to participate in this study.

Exclusion Criteria:

  • There is no demographic restriction on participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Medical staff
Medical staff who work at the Department of Obstetrics and Gynecology or Women Health Units in Asia and Oceania countries.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
KAP towards VAW
Time Frame: through study completion, an average of 1 year
Using questionnaire to explore the levels of KAP towards VAW among medical staff
through study completion, an average of 1 year
KAP towards support service of VAW
Time Frame: through study completion, an average of 1 year
Using questionnaire to explore the levels of KAP towards support service of VAW among medical staff
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Unnop Jaisamrarn, MD,MHS, Chulalongkorn University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2025

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

October 1, 2025

Study Registration Dates

First Submitted

March 19, 2024

First Submitted That Met QC Criteria

March 27, 2024

First Posted (Actual)

March 28, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 11, 2025

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Since this is the multinational survey, we will decide after discussing with investigators of each country.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Violence Against Women

Subscribe